linagliptin and its Impurities

Linagliptin is a medication used to treat diabetes mellitus type 2. It is sold under the brand name Tradjenta. It is used together with exercise and diet. Reference standards of Linagliptin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 100 results for linagliptin Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 12 47000

Linagliptin

Linagliptin


  • Catalogue No.:PA 12 47000

  • CAS :

    668270-12-0

  • Molecular Formula : C25H28N8O2

  • Molecular Weight : 472.54

Drug Reference Standards & Impurity Synthesis in India
PA 12 47510

Linagliptin Diene Impurity

Linagliptin Diene Impurity


  • Catalogue No.:PA 12 47510

  • CAS :

    2463617-43-6

  • Molecular Formula : C25H28N8O2

  • Molecular Weight : 472.54

Drug Reference Standards & Impurity Synthesis in India
PA 12 47520

Linagliptin Dimer Impurity

Linagliptin Dimer Impurity


  • Catalogue No.:PA 12 47520

  • CAS :

    NA

  • Molecular Formula : C52H59N17O4

  • Molecular Weight : 986.14

Drug Reference Standards & Impurity Synthesis in India
PA 12 47530

8-[(3R)-3-Amino-1-piperidinyl]-7-[(2E)-3-bromo-2-buten-1-yl]-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-Purine-2,6-dione

8-[(3R)-3-Amino-1-piperidinyl]-7-[(2E)-3-bromo-2-buten-1-yl]-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-Purine-2,6-dione


  • Catalogue No.:PA 12 47530

  • CAS :

    1446263-39-3

  • Molecular Formula : C25H29BrN8O2

  • Molecular Weight : 553.45

Drug Reference Standards & Impurity Synthesis in India
PA 12 47540

(R)-7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione

(R)-7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione


  • Catalogue No.:PA 12 47540

  • CAS :

    1446263-38-2

  • Molecular Formula : C25H28N8O2

  • Molecular Weight : 472.54

Drug Reference Standards & Impurity Synthesis in India
PA 12 47550

Linagliptin N,N’-Methylene Dimer

Linagliptin N,N’-Methylene Dimer


  • Catalogue No.:PA 12 47550

  • CAS :

    2489212-72-6

  • Molecular Formula : C51H56N16O4

  • Molecular Weight : 957.1

Drug Reference Standards & Impurity Synthesis in India
PA 12 47560

Linagliptin N-Formyl Impurity

Linagliptin N-Formyl Impurity


  • Catalogue No.:PA 12 47560

  • CAS :

    2137744-33-1

  • Molecular Formula : C26H28N8O3

  • Molecular Weight : 500.55

Drug Reference Standards & Impurity Synthesis in India
PA 12 47570

Linagliptin N-Aminoacyl Impurity

Linagliptin N-Aminoacyl Impurity


  • Catalogue No.:PA 12 47570

  • CAS :

    2983074-55-9

  • Molecular Formula : C26H29N9O3

  • Molecular Weight : 515.57

Drug Reference Standards & Impurity Synthesis in India
PA 12 47580

Linagliptin N-Acetyl Impurity

Linagliptin N-Acetyl Impurity


  • Catalogue No.:PA 12 47580

  • CAS :

    1803079-49-3

  • Molecular Formula : C27H30N8O3

  • Molecular Weight : 514.58

Drug Reference Standards & Impurity Synthesis in India
PA 12 47590

8-Bromo-3-methyl-7-(2-butynyl)-xanthine

8-Bromo-3-methyl-7-(2-butynyl)-xanthine


  • Catalogue No.:PA 12 47590

  • CAS :

    666816-98-4

  • Molecular Formula : C10H9BrN4O2

  • Molecular Weight : 297.11

Drug Reference Standards & Impurity Synthesis in India
PA 12 47600

8-Bromo-3,9-dihydro-3-methyl-1H-purine-2,6-dione

8-Bromo-3,9-dihydro-3-methyl-1H-purine-2,6-dione


  • Catalogue No.:PA 12 47600

  • CAS :

    93703-24-3

  • Molecular Formula : C6H5BrN4O2

  • Molecular Weight : 245.03

Drug Reference Standards & Impurity Synthesis in India
PA 12 47610

1-Bromo-2-butyne

1-Bromo-2-butyne


  • Catalogue No.:PA 12 47610

  • CAS :

    3355-28-0

  • Molecular Formula : C4H5Br

  • Molecular Weight : 132.99

Drug Reference Standards & Impurity Synthesis in India
PA 12 47620

2-Butyn-1-ol

2-Butyn-1-ol


  • Catalogue No.:PA 12 47620

  • CAS :

    764-01-2

  • Molecular Formula : C4H6O

  • Molecular Weight : 70.09

Drug Reference Standards & Impurity Synthesis in India
PA 12 47630

2-(Chloromethyl)-4-methylquinazoline

2-(Chloromethyl)-4-methylquinazoline


  • Catalogue No.:PA 12 47630

  • CAS :

    109113-72-6

  • Molecular Formula : C10H9ClN2

  • Molecular Weight : 192.64

Drug Reference Standards & Impurity Synthesis in India
PA 12 47640

2-(Chloromethyl)quinazoline

2-(Chloromethyl)quinazoline


  • Catalogue No.:PA 12 47640

  • CAS :

    6148-18-1

  • Molecular Formula : C9H7ClN2

  • Molecular Weight : 178.62

Drug Reference Standards & Impurity Synthesis in India
PA 12 47650

Linagliptin S-Isomer

Linagliptin S-Isomer


  • Catalogue No.:PA 12 47650

  • CAS :

    668270-11-9

  • Molecular Formula : C25H28N8O2

  • Molecular Weight : 472.54

Drug Reference Standards & Impurity Synthesis in India
PA 12 47660

(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-2H-purin-2-one Tartrate

(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-2H-purin-2-one Tartrate


  • Catalogue No.:PA 12 47660

  • CAS :

    NA

  • Molecular Formula : C29H34N8O8

  • Molecular Weight : 622.63

Drug Reference Standards & Impurity Synthesis in India
PA 12 47670

N-Depiperidin-3-amine Linagliptin Dimer

N-Depiperidin-3-amine Linagliptin Dimer


  • Catalogue No.:PA 12 47670

  • CAS :

    2253964-98-4

  • Molecular Formula : C45H44N14O4

  • Molecular Weight : 844.92

Drug Reference Standards & Impurity Synthesis in India
PA 12 47680

8-Bromo-7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-2,3-dihydro-1H-purin-6(7H)-one

8-Bromo-7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-2,3-dihydro-1H-purin-6(7H)-one


  • Catalogue No.:PA 12 47680

  • CAS :

    NA

  • Molecular Formula : C20H19BrN6O2

  • Molecular Weight : 455.31

Drug Reference Standards & Impurity Synthesis in India
PA 12 47690

(E)-2-Buten-1-ol

(E)-2-Buten-1-ol


  • Catalogue No.:PA 12 47690

  • CAS :

    504-61-0

  • Molecular Formula : C4H8O

  • Molecular Weight : 72.11

Drug Reference Standards & Impurity Synthesis in India
PA 12 47700

(2E)-1,3-Dibromo-2-butene

(2E)-1,3-Dibromo-2-butene


  • Catalogue No.:PA 12 47700

  • CAS :

    86365-83-5

  • Molecular Formula : C4H6Br2

  • Molecular Weight : 213.9

Drug Reference Standards & Impurity Synthesis in India
PA 12 47710

(Z)-2-Buten-1-ol

(Z)-2-Buten-1-ol


  • Catalogue No.:PA 12 47710

  • CAS :

    4088-60-2

  • Molecular Formula : C4H8O

  • Molecular Weight : 72.11

Drug Reference Standards & Impurity Synthesis in India
PA 12 47720

(2Z)-1,3-Dibromo-2-butene

(2Z)-1,3-Dibromo-2-butene


  • Catalogue No.:PA 12 47720

  • CAS :

    86365-84-6

  • Molecular Formula : C4H6Br2

  • Molecular Weight : 213.9

Drug Reference Standards & Impurity Synthesis in India
PA 12 47730

(S)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide

(S)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide


  • Catalogue No.:PA 12 47730

  • CAS :

    NA

  • Molecular Formula : C26H28N8O3

  • Molecular Weight : 500.55

Drug Reference Standards & Impurity Synthesis in India
PA 12 47740

8-Bromo-7-(but-2-en-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-2H-purin-2-one

8-Bromo-7-(but-2-en-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-2H-purin-2-one


  • Catalogue No.:PA 12 47740

  • CAS :

    NA

  • Molecular Formula : C20H19BrN6O2

  • Molecular Weight : 455.31

Drug Reference Standards & Impurity Synthesis in India
PA 12 47750

tert-Butyl (1-benzylpiperidin-3-yl)carbamate

tert-Butyl (1-benzylpiperidin-3-yl)carbamate


  • Catalogue No.:PA 12 47750

  • CAS :

    478828-62-5

  • Molecular Formula : C17H26N2O2

  • Molecular Weight : 290.4

Drug Reference Standards & Impurity Synthesis in India
PA 12 47760

4,4'-(2-Methylpropane-1,3-diyl)bis(2-(chloromethyl)quinazoline)

4,4'-(2-Methylpropane-1,3-diyl)bis(2-(chloromethyl)quinazoline)


  • Catalogue No.:PA 12 47760

  • CAS :

    2638512-67-9

  • Molecular Formula : C22H20Cl2N4

  • Molecular Weight : 411.33

Drug Reference Standards & Impurity Synthesis in India
PA 12 47770

8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione


  • Catalogue No.:PA 12 47770

  • CAS :

    853029-57-9

  • Molecular Formula : C20H17BrN6O2

  • Molecular Weight : 453.29

Drug Reference Standards & Impurity Synthesis in India
PA 12 47780

(R)-7-(But-2-yn-1-yl)-3-methyl-8-(3-(5-methyl-1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

(R)-7-(But-2-yn-1-yl)-3-methyl-8-(3-(5-methyl-1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione


  • Catalogue No.:PA 12 47780

  • CAS :

    1573118-33-8

  • Molecular Formula : C34H32N8O4

  • Molecular Weight : 616.67

Drug Reference Standards & Impurity Synthesis in India
PA 12 47790

7-(But-2-yn-1-yl)-8-((R)-3-(((((S)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)amino)methyl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

7-(But-2-yn-1-yl)-8-((R)-3-(((((S)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)amino)methyl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione


  • Catalogue No.:PA 12 47790

  • CAS :

    NA

  • Molecular Formula : C51H56N16O4

  • Molecular Weight : 957.1

Drug Reference Standards & Impurity Synthesis in India
PA 12 47800

8-((3R)-3-((1-(2-((8-((R)-3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,4,5,6,7-hexahydro-1H-purin-1-yl)methyl)quinazolin-4-yl)propan-2-yl)amino)piperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

8-((3R)-3-((1-(2-((8-((R)-3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,4,5,6,7-hexahydro-1H-purin-1-yl)methyl)quinazolin-4-yl)propan-2-yl)amino)piperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione


  • Catalogue No.:PA 12 47800

  • CAS :

    NA

  • Molecular Formula : C52H60N16O4

  • Molecular Weight : 973.14

Drug Reference Standards & Impurity Synthesis in India
PA STI 056610

Linagliptin-d3

Linagliptin-d3


  • Catalogue No.:PA STI 056610

  • CAS :

    1398044-48-8

  • Molecular Formula : C25H25D3N8O2

  • Molecular Weight : 475.56

Drug Reference Standards & Impurity Synthesis in India
PA STI 056611

Linagliptin-13C,d3

Linagliptin-13C,d3


  • Catalogue No.:PA STI 056611

  • CAS :

    1398044-43-3

  • Molecular Formula : C2413CH25D3N8O2

  • Molecular Weight : 476.56

Drug Reference Standards & Impurity Synthesis in India
PA 12 47810

(4-Methylquinazolin-2-yl)methanol

(4-Methylquinazolin-2-yl)methanol


  • Catalogue No.:PA 12 47810

  • CAS :

    13535-91-6

  • Molecular Formula : C10H10N2O

  • Molecular Weight : 174.2

Drug Reference Standards & Impurity Synthesis in India
PA 12 47820

(S)-7-(but-2-yn-1-yl)-3-Methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-3,7-dihydro-1H-purine-2,6-dione

(S)-7-(but-2-yn-1-yl)-3-Methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 47820

  • CAS :

    2253964-85-9

  • Molecular Formula : C25H28N8O2

  • Molecular Weight : 472.55

Drug Reference Standards & Impurity Synthesis in India
PA 12 47830

7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione

7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione


  • Catalogue No.:PA 12 47830

  • CAS :

    1911621-52-7

  • Molecular Formula : C20H18N6O2

  • Molecular Weight : 374.4

Drug Reference Standards & Impurity Synthesis in India
PA 12 47840

(R)-(1-(7-(but-2-yn-1-yl)-3-Methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)(tert-butyl)carbamic Acid

(R)-(1-(7-(but-2-yn-1-yl)-3-Methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)(tert-butyl)carbamic Acid


  • Catalogue No.:PA 12 47840

  • CAS :

    NA

  • Molecular Formula : C30H36N8O4

  • Molecular Weight : 572.67

Drug Reference Standards & Impurity Synthesis in India
PA 12 47850

(R)-8-(3-Aminopiperidin-1-yl)-1-(but-2-yn-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

(R)-8-(3-Aminopiperidin-1-yl)-1-(but-2-yn-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 47850

  • CAS :

    NA

  • Molecular Formula : C25H28N8O2

  • Molecular Weight : 472.55

Drug Reference Standards & Impurity Synthesis in India
PA 12 47860

(R)-7-(But-2-yn-1-yl)-8-(3-(hydroxyamino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

(R)-7-(But-2-yn-1-yl)-8-(3-(hydroxyamino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 47860

  • CAS :

    NA

  • Molecular Formula : C25H28N8O3

  • Molecular Weight : 488.55

Drug Reference Standards & Impurity Synthesis in India
PA 12 47870

(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-6H-purin-6-one

(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-6H-purin-6-one


  • Catalogue No.:PA 12 47870

  • CAS :

    NA

  • Molecular Formula : C25H28N8O2

  • Molecular Weight : 472.55

Drug Reference Standards & Impurity Synthesis in India
PA 12 47880

N-Boc Linagliptin

N-Boc Linagliptin


  • Catalogue No.:PA 12 47880

  • CAS :

    668273-75-4

  • Molecular Formula : C30H36N8O4

  • Molecular Weight : 572.67

Drug Reference Standards & Impurity Synthesis in India
PA 12 47890

(R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

(R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 47890

  • CAS :

    1638744-06-5

  • Molecular Formula : C25H29BrN8O2

  • Molecular Weight : 553.47

Drug Reference Standards & Impurity Synthesis in India
PA 12 47900

5,6-Diamino-1-methylpyrimidine-2,4(1H,3H)-dione

5,6-Diamino-1-methylpyrimidine-2,4(1H,3H)-dione


  • Catalogue No.:PA 12 47900

  • CAS :

    6972-82-3

  • Molecular Formula : C5H8N4O2

  • Molecular Weight : 156.15

Drug Reference Standards & Impurity Synthesis in India
PA 12 47910

8-Bromo-3-methyl-9-(2-butynyl)-xanthine

8-Bromo-3-methyl-9-(2-butynyl)-xanthine


  • Catalogue No.:PA 12 47910

  • CAS :

    2512206-89-0

  • Molecular Formula : C10H9BrN4O2

  • Molecular Weight : 297.11

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471000

(S)-1-Benzyl-3-Boc-aminopiperidine

(S)-1-Benzyl-3-Boc-aminopiperidine


  • Catalogue No.:PA 12 0471000

  • CAS :

    216854-24-9

  • Molecular Formula : C17H26N2O2

  • Molecular Weight : 290.41

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471001

(S)-2-((tert-Butoxycarbonyl)amino)pentane-1,5-diyl Dimethanesulfonate

(S)-2-((tert-Butoxycarbonyl)amino)pentane-1,5-diyl Dimethanesulfonate


  • Catalogue No.:PA 12 0471001

  • CAS :

    607376-86-3

  • Molecular Formula : C12H25NO8S2

  • Molecular Weight : 375.45

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471002

3-Methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tertbutyloxycarbonylamino)piperidin-1-yl]-xanthine

3-Methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tertbutyloxycarbonylamino)piperidin-1-yl]-xanthine


  • Catalogue No.:PA 12 0471002

  • CAS :

    666816-91-7

  • Molecular Formula : C20H28N6O4

  • Molecular Weight : 416.48

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471003

(R)-1-Benzyl-3-Boc-Aminopiperidine

(R)-1-Benzyl-3-Boc-Aminopiperidine


  • Catalogue No.:PA 12 0471003

  • CAS :

    454713-13-4

  • Molecular Formula : C17H26N2O2

  • Molecular Weight : 290.41

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471004

(R)-3-(Boc-Amino)piperidine

(R)-3-(Boc-Amino)piperidine


  • Catalogue No.:PA 12 0471004

  • CAS :

    309956-78-3

  • Molecular Formula : C10H20N2O2

  • Molecular Weight : 200.28

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471005

Linagliptin Methyldimer

Linagliptin Methyldimer


  • Catalogue No.:PA 12 0471005

  • CAS :

    1418133-47-7

  • Molecular Formula : C50H56N16O4

  • Molecular Weight : 945.11

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471006

(R)-8-(3-Aminopiperidin-1-yl)-3,7-dimethyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

(R)-8-(3-Aminopiperidin-1-yl)-3,7-dimethyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione


  • Catalogue No.:PA 12 0471006

  • CAS :

    1339955-47-3

  • Molecular Formula : C22H26N8O2

  • Molecular Weight : 434.5

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471007

8-Bromo-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

8-Bromo-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471007

  • CAS :

    2138392-83-1

  • Molecular Formula : C26H21BrN8O2

  • Molecular Weight : 557.41

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471008

Linagliptin Metabolite CD1790

Linagliptin Metabolite CD1790


  • Catalogue No.:PA 12 0471008

  • CAS :

    NA

  • Molecular Formula : C25H27N7O3

  • Molecular Weight : 473.54

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471009

N-Phthalimide-linagliptin

N-Phthalimide-linagliptin


  • Catalogue No.:PA 12 0471009

  • CAS :

    886588-63-2

  • Molecular Formula : C33H30N8O4

  • Molecular Weight : 602.66

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471010

7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(3-((3,4,5,6-tetrahydroxy-2-oxohexyl)amino)piperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione

7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(3-((3,4,5,6-tetrahydroxy-2-oxohexyl)amino)piperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471010

  • CAS :

    NA

  • Molecular Formula : C31H38N8O7

  • Molecular Weight : 634.69

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471011

(R)-7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(3-nitrosopiperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione

(R)-7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(3-nitrosopiperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471011

  • CAS :

    NA

  • Molecular Formula : C25H26N8O3

  • Molecular Weight : 486.54

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471012

8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-Methylquinazolin-2-yl)Methyl)-3,7-dihydro-1H-purine-2,6-dione

8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-Methylquinazolin-2-yl)Methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471012

  • CAS :

    1383917-84-7

  • Molecular Formula : C25H28N8O2

  • Molecular Weight : 472.55

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471013

8-((R)-3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-1-((4-(2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)amino)ethyl)quinazolin-2-yl)methyl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione

8-((R)-3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-1-((4-(2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)amino)ethyl)quinazolin-2-yl)methyl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471013

  • CAS :

    NA

  • Molecular Formula : C51H56N16O4

  • Molecular Weight : 957.12

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471014

8-((R)-3-Aminopiperidin-1-yl)-1-((4-(3-(2-((8-((S)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)quinazolin-4-yl)-2-(4-methylquinazolin-2-yl)propyl)quinazolin-2-yl)methyl)-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione

8-((R)-3-Aminopiperidin-1-yl)-1-((4-(3-(2-((8-((S)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)quinazolin-4-yl)-2-(4-methylquinazolin-2-yl)propyl)quinazolin-2-yl)methyl)-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471014

  • CAS :

    NA

  • Molecular Formula : C60H62N18O4

  • Molecular Weight : 1099.28

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471015

7-(but-2-yn-1-yl)-3-Methyl-1-((4-methylquinazolin-2-yl)methyl)-8-((3R)-3-(((Z)-2,3,4,5,6-pentahydroxyhex-1-en-1-yl)amino)piperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione

7-(but-2-yn-1-yl)-3-Methyl-1-((4-methylquinazolin-2-yl)methyl)-8-((3R)-3-(((Z)-2,3,4,5,6-pentahydroxyhex-1-en-1-yl)amino)piperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471015

  • CAS :

    NA

  • Molecular Formula : C31H38N8O7

  • Molecular Weight : 634.69

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471016

N-(2-Acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide

N-(2-Acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide


  • Catalogue No.:PA 12 0471016

  • CAS :

    2279114-31-5

  • Molecular Formula : C20H18BrN5O4

  • Molecular Weight : 472.3

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471017

7-(but-2-yn-1-yl)-8-(Dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

7-(but-2-yn-1-yl)-8-(Dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471017

  • CAS :

    1646355-34-1

  • Molecular Formula : C22H23N7O2

  • Molecular Weight : 417.47

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471018

 Tert-butyl (R)-(1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

Tert-butyl (R)-(1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate


  • Catalogue No.:PA 12 0471018

  • CAS :

    2518331-40-1

  • Molecular Formula : C24H32N6O4

  • Molecular Weight : 468.56

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471019

Tert-butyl (R)-(1-(3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

Tert-butyl (R)-(1-(3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate


  • Catalogue No.:PA 12 0471019

  • CAS :

    NA

  • Molecular Formula : C26H32N8O4

  • Molecular Weight : 520.59

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471020

N-((R)-Piperidin-3-yl)-N'-((S)-piperidin-3-yl)methanediamine

N-((R)-Piperidin-3-yl)-N'-((S)-piperidin-3-yl)methanediamine


  • Catalogue No.:PA 12 0471020

  • CAS :

    NA

  • Molecular Formula : C11H24N4

  • Molecular Weight : 212.34

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471021

(R)-8-(3-Aminopiperidin-1-yl)-7-(buta-2,3-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

(R)-8-(3-Aminopiperidin-1-yl)-7-(buta-2,3-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471021

  • CAS :

    NA

  • Molecular Formula : C25H28N8O2

  • Molecular Weight : 472.55

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471022

8-Bromo-7-(but-2-yn-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-1,3,6,7-tetrahydro-2H-purin-2-one

8-Bromo-7-(but-2-yn-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-1,3,6,7-tetrahydro-2H-purin-2-one


  • Catalogue No.:PA 12 0471022

  • CAS :

    NA

  • Molecular Formula : C20H19BrN6O2

  • Molecular Weight : 455.32

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471023

(R)-7-(but-2-yn-1-yl)-3-Methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(3-(((4-methylquinazolin-2-yl)methyl)amino)piperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione

(R)-7-(but-2-yn-1-yl)-3-Methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(3-(((4-methylquinazolin-2-yl)methyl)amino)piperidin-1-yl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471023

  • CAS :

    NA

  • Molecular Formula : C35H36N10O2

  • Molecular Weight : 628.74

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471024

8-((S)-3-Aminopiperidin-1-yl)-1-((4-((2-((8-((S)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)-4-methyl-3,4-dihydroquinazolin-4-yl)methyl)quinazolin-2-yl)methyl)-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione Trihydrochloride

8-((S)-3-Aminopiperidin-1-yl)-1-((4-((2-((8-((S)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)-4-methyl-3,4-dihydroquinazolin-4-yl)methyl)quinazolin-2-yl)methyl)-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione Trihydrochloride


  • Catalogue No.:PA 12 0471024

  • CAS :

    NA

  • Molecular Formula : C50H59Cl3N16O4

  • Molecular Weight : 1054.48

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471025

(R)-N-(2-Acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide

(R)-N-(2-Acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide


  • Catalogue No.:PA 12 0471025

  • CAS :

    2416949-69-2

  • Molecular Formula : C25H29N7O4

  • Molecular Weight : 491.55

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471026

(R)-7-(But-2-yn-1-yl)-8-(3-(2,2-dimethylhydrazinyl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

(R)-7-(But-2-yn-1-yl)-8-(3-(2,2-dimethylhydrazinyl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471026

  • CAS :

    NA

  • Molecular Formula : C27H33N9O2

  • Molecular Weight : 515.62

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471027

7-(But-2-yn-1-yl)-8-hydroxy-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

7-(But-2-yn-1-yl)-8-hydroxy-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471027

  • CAS :

    NA

  • Molecular Formula : C20H18N6O3

  • Molecular Weight : 390.4

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471028

(R)-(1-(3,7-Dimethyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamic acid

(R)-(1-(3,7-Dimethyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamic acid


  • Catalogue No.:PA 12 0471028

  • CAS :

    NA

  • Molecular Formula : C23H26N8O4

  • Molecular Weight : 478.51

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471029

(R)-1-((4-Methylquinazolin-2-yl)methyl)piperidin-3-amine

(R)-1-((4-Methylquinazolin-2-yl)methyl)piperidin-3-amine


  • Catalogue No.:PA 12 0471029

  • CAS :

    NA

  • Molecular Formula : C15H20N4

  • Molecular Weight : 256.35

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471030

Linagliptin Tartaric acid Impurity

Linagliptin Tartaric acid Impurity


  • Catalogue No.:PA 12 0471030

  • CAS :

    NA

  • Molecular Formula : C29H32N8O7

  • Molecular Weight : 604.62

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471031

Hydroxy Methyl Linagliptin

Hydroxy Methyl Linagliptin


  • Catalogue No.:PA 12 0471031

  • CAS :

    NA

  • Molecular Formula : C27H34N8O3

  • Molecular Weight : 518.62

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471032

Trifluoro acetyl amino Linagliptin

Trifluoro acetyl amino Linagliptin


  • Catalogue No.:PA 12 0471032

  • CAS :

    1673546-62-7

  • Molecular Formula : C27H27F3N8O3

  • Molecular Weight : 568.56

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471033

2-Cyano-N-(methylcarbamoyl)acetamide

2-Cyano-N-(methylcarbamoyl)acetamide


  • Catalogue No.:PA 12 0471033

  • CAS :

    6972-77-6

  • Molecular Formula : C5H7N3O2

  • Molecular Weight : 141.13

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471034

8-((R)-3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-1-((4-(2-(((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)amino)ethyl)quinazolin-2-yl)methyl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione

8-((R)-3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-1-((4-(2-(((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)amino)ethyl)quinazolin-2-yl)methyl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471034

  • CAS :

    2463617-49-2

  • Molecular Formula : C51H56N16O4

  • Molecular Weight : 957.12

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471036

(R)-8-(3-Aminopiperidin-1-yl)-7-(4-hydroxybut-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

(R)-8-(3-Aminopiperidin-1-yl)-7-(4-hydroxybut-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471036

  • CAS :

    1807608-59-8

  • Molecular Formula : C25H28N8O3

  • Molecular Weight : 488.55

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471035

(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-2H-purin-2-one

(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-6-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-2H-purin-2-one


  • Catalogue No.:PA 12 0471035

  • CAS :

    2514724-20-8

  • Molecular Formula : C25H28N8O2

  • Molecular Weight : 472.55

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471037

(E)-8-Bromo-7-(3-bromobut-2-en-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione

(E)-8-Bromo-7-(3-bromobut-2-en-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471037

  • CAS :

    NA

  • Molecular Formula : C10H10Br2N4O2

  • Molecular Weight : 378.02

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471038

7-(But-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione

7-(But-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471038

  • CAS :

    586408-08-4

  • Molecular Formula : C10H10N4O2

  • Molecular Weight : 218.22

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471039

8-Bromo-1,7-di(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione

8-Bromo-1,7-di(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471039

  • CAS :

    2436762-89-7

  • Molecular Formula : C14H13BrN4O2

  • Molecular Weight : 349.19

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471040

8-Bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

8-Bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471040

  • CAS :

    2749405-42-1

  • Molecular Formula : C16H13BrN6O2

  • Molecular Weight : 401.22

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471041

8-Bromo-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

8-Bromo-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471041

  • CAS :

    NA

  • Molecular Formula : C20H18Br2N6O2

  • Molecular Weight : 534.21

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471042

7-((1,3-Dioxolan-2-yl)methyl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione

7-((1,3-Dioxolan-2-yl)methyl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471042

  • CAS :

    123524-29-8

  • Molecular Formula : C10H12N4O4

  • Molecular Weight : 252.23

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471043

1,7-Di(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione

1,7-Di(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471043

  • CAS :

    NA

  • Molecular Formula : C14H14N4O2

  • Molecular Weight : 270.29

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471044

(Z)-7-(3-Bromobut-2-en-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione

(Z)-7-(3-Bromobut-2-en-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471044

  • CAS :

    NA

  • Molecular Formula : C10H11BrN4O2

  • Molecular Weight : 299.13

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471045

(R)-8-(3-Aminopiperidin-1-yl)-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

(R)-8-(3-Aminopiperidin-1-yl)-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471045

  • CAS :

    NA

  • Molecular Formula : C31H32N10O2

  • Molecular Weight : 576.67

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471046

(R)-2-Tert-butyloxycarbonylamino-pentane-1,5-diol

(R)-2-Tert-butyloxycarbonylamino-pentane-1,5-diol


  • Catalogue No.:PA 12 0471046

  • CAS :

    397246-12-7

  • Molecular Formula : C10H21NO4

  • Molecular Weight : 219.28

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471047

N-(6-Amino-1,2,3,4-tetrahydro-1-methyl-2,4-dioxo-5-pyrimidinyl)formamide

N-(6-Amino-1,2,3,4-tetrahydro-1-methyl-2,4-dioxo-5-pyrimidinyl)formamide


  • Catalogue No.:PA 12 0471047

  • CAS :

    14785-95-6

  • Molecular Formula : C6H8N4O3

  • Molecular Weight : 184.16

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471048

7-(But-2-yn-1-yl)-3-methyl-8-(methylamino)-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

7-(But-2-yn-1-yl)-3-methyl-8-(methylamino)-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471048

  • CAS :

    2468656-63-3

  • Molecular Formula : C21H21N7O2

  • Molecular Weight : 403.45

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471052

(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione

(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471052

  • CAS :

    1791405-13-4

  • Molecular Formula : C15H20N6O2

  • Molecular Weight : 316.37

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471049

(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-1-((4-methylquinazolin-2-yl)methyl)-3-nitroso-3,7-dihydro-1H-purine-2,6-dione

(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-1-((4-methylquinazolin-2-yl)methyl)-3-nitroso-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471049

  • CAS :

    NA

  • Molecular Formula : C24H25N9O3

  • Molecular Weight : 487.52

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471050

(R)-8-(3-Aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-nitroso-3,7-dihydro-1H-purine-2,6-dione

(R)-8-(3-Aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-nitroso-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471050

  • CAS :

    NA

  • Molecular Formula : C21H23N9O3

  • Molecular Weight : 449.48

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471051

(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-nitroso-3,7-dihydro-1H-purine-2,6-dione

(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-nitroso-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471051

  • CAS :

    NA

  • Molecular Formula : C15H19N7O3

  • Molecular Weight : 345.36

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471053

(R,E)-8-(3-Aminopiperidin-1-yl)-7-(4-hydroxy-3-methylbut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione

(R,E)-8-(3-Aminopiperidin-1-yl)-7-(4-hydroxy-3-methylbut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione


  • Catalogue No.:PA 12 0471053

  • CAS :

    NA

  • Molecular Formula : C26H32N8O3

  • Molecular Weight : 504.6

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471054

tert-Butyl (R)-3-aminopiperidine-1-carboxylate

tert-Butyl (R)-3-aminopiperidine-1-carboxylate


  • Catalogue No.:PA 12 0471054

  • CAS :

    188111-79-7

  • Molecular Formula : C10H20N2O2

  • Molecular Weight : 200.28

Drug Reference Standards & Impurity Synthesis in India
PA 12 0471055

1-(2-(((4-Methylquinazolin-2-yl)methyl)amino)phenyl)ethan-1-one

1-(2-(((4-Methylquinazolin-2-yl)methyl)amino)phenyl)ethan-1-one


  • Catalogue No.:PA 12 0471055

  • CAS :

    NA

  • Molecular Formula : C18H17N3O

  • Molecular Weight : 291.35

pharmaffiliates